StockWatch
·
Specialty Chemicals
Rights Issue15 May 2026, 05:21 pm

Camlin Fine Sciences: Rights Issue Monitoring Report

AI Summary

Camlin Fine Sciences Ltd. has released the Monitoring Agency Report for the quarter ended March 31, 2026, regarding the utilization of funds raised through its Rights Issue. The report, prepared by India Ratings & Research Private Limited, confirms no deviation in the use of issue proceeds from the stated objectives in the Letter of Offer. The Audit Committee reviewed and approved the report on May 12, 2026, followed by the Board of Directors on May 15, 2026.

Key Highlights

  • Monitoring Agency confirms no deviation in Rights Issue proceeds utilization.
  • India Ratings & Research Private Limited prepared the monitoring report.
  • Audit Committee approved the report on May 12, 2026.
  • Board of Directors approved the report on May 15, 2026.
  • Rights Issue involved 2,04,26,244 Equity Shares at ₹110 each.